A method for simultaneous determination of ticagrelor and its active metabolites and endogenous adenosine concentrations in human plasma by liquid chromatography-mass spectrometry
A technology of ticagrelor and liquid chromatography-mass spectrometry, applied in the field of medical testing, to achieve the effect of less blood sample consumption, good repeatability, and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1 Pre-experiment
[0048] 1. Experimental materials
[0049] 30% perchloric acid, 30% acetonitrile, 50% acetonitrile, 80% acetonitrile, 100% acetonitrile, ticagrelor, AR-C124910XX
[0050] 2. Experimental method
[0051] Adenosine in the sample to be tested is unstable, so the present invention selects 30% perchloric acid to precipitate protein, effectively removes enzymes in biological samples, and ensures that the concentration of adenosine is stable after pretreatment.
[0052] 3. Experimental results
[0053] In the present invention, the analyte of adenosine is a very polar compound, while ticagrelor and its active metabolite are very weak. Therefore, the present invention examines the ratio of organic solvents in different proportions. After dissolving perchloric acid, its extraction and recovery rate difference, see Table 1.
[0054] Table 1, different proportions of acetonitrile-aqueous solution dissolved perchloric acid to investigate the extraction...
Embodiment 2
[0058] Example 2 Selectivity and Linearity Test
[0059] 1. Experimental method
[0060] Biological blank matrix treatment: Put the plasma sample for a period of time until the adenosine disappears completely (the adenosine can disappear completely in 2 hours), add 50 μl of stabilizer to 1 ml of plasma, and mix the plasma for use.
[0061] Linear test:
[0062] Configure a series of standard curve plasma samples, including adenosine concentrations of 110, 55, 11, 5.5, 3.3, 2.2ng / mL; ticagrelor 1600, 800, 160, 80, 48, 32ng / mL; ticagrelor activity Metabolites 1108, 554, 110.8, 55.4, 33.2, 22.2 ng / mL. According to the plasma sample pretreatment operation. Take the concentration of the analyte (C, ng / mL) as the abscissa, and the ratio (As / Ai) of the peak area of the analyte (As) to the peak area of the internal standard (Ai) as the ordinate, using the weighting (weight coefficient: 1 / C 2 ) least squares method was used for linear regression, and the correlation coefficie...
Embodiment 3
[0069] Example 3 Extraction recovery and matrix effect
[0070] 1. Experimental method
[0071] The blank plasma treated with blank matrix was taken, except that the standard series solution and internal standard solution were not added, and the supernatant was prepared according to the "plasma sample pretreatment method" in Example 2. The corresponding concentration standard series solution and internal standard were added to the supernatant, and 5 samples were analyzed for each concentration, and the corresponding peak area value A was obtained. Take 200 μL of blank plasma treated with blank matrix, prepare standard series solutions of corresponding concentrations and internal standard solutions, operate according to the "plasma sample pretreatment method" in Example 2, and analyze 5 samples for each concentration to obtain the corresponding peak area value B. In addition to preparing the corresponding concentration standard series solution and internal standard solution, 5...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com